Susquehanna International Group
WINT

Susquehanna International Group’s Windtree Therapeutics Inc WINT Stock Holding History

Susquehanna International Group’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,893
Closed -$65K – 10707
2015
Q1 		$65K Sell
3,893
-4,264
-52% -$83.9K ﹤0.01% 9096
2014
Q4 		$132K Sell
8,157
-5,993
-42% -$132K ﹤0.01% 9075
2014
Q3 		$365K Buy
14,150
+4,779
+51% +$115K ﹤0.01% 7734
2014
Q2 		$234K Buy
9,371
+542
+6% +$13.9K ﹤0.01% 8807
2014
Q1 		$266K Buy
8,829
+458
+5% +$15.4K ﹤0.01% 7781
2013
Q4 		$264K Buy
8,371
+4,000
+92% +$125K ﹤0.01% 7794
2013
Q3 		$120K Sell
4,371
-472
-10% -$11.4K ﹤0.01% 8014
2013
Q2 		$103K Buy
+4,843
New +$119K ﹤0.01% 7779

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Susquehanna International Group's WINT Position: Q3 2015 in Review

Susquehanna International Group sold out of Windtree Therapeutics Inc (WINT) in Q3 2015, closing a stake of 2,889 shares — an estimated $19.1K sold.

Susquehanna International Group first reported a position in WINT in Q2 2013 and held it in 8 quarters. The position peaked at $710K in Q1 2014. 48 funds tracked by Wall St. Rank hold WINT as of Q3 2015.

  • Susquehanna International Group reported no remaining Windtree Therapeutics Inc position as of Q3 2015 after selling out during the quarter.
  • Susquehanna International Group sold 2,889 Windtree Therapeutics Inc shares in Q3 2015, an estimated $19.1K.
  • Susquehanna International Group first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 8 quarters.
  • Susquehanna International Group's Windtree Therapeutics Inc position peaked at $710K in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.